NCT02063113|Terminated
Study Stopped
inclusion difficulty
Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
MYELOME-PA
Loading search results
Sponsor study identifier
interventional
48
1 country
2
Study Start
May 19, 2014
Actual (reported)Primary Completion
November 28, 2018
Actual (reported)Study Completion
November 28, 2018
Actual (reported)The aim of this study is to determine whether the presence of vulnerability detected by geriatricians is associated with treatment discontinuation in older patient. During the comprehensive geriatric assessment realized before the decision-treatment, the following data are recorded and their impact in the therapeutic changes will also be analysed: comorbidity, age, depression, functional status, the cognitive impairment and malnutrition.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 28, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 11, 2014
Actual (reported)February 14, 2014
Actual (reported)May 19, 2014
Actual (reported)November 28, 2018
Actual (reported)November 28, 2018
Actual (reported)The occurrence of the events
The primary outcome is either : * early interruption of treatment * dose reduction \> 20% during treatment * discontinuous treatment These outcomes will be measured every 6 months during the 2 years of follow up
6 MONTHS
Type of Vulnerability
6 MONTHS
Therapeutic changes
6 MONTHS
Toxicity during treatment
6 months
Progression to 1 and 2 years
1 year/2year
Complete response at 1 and 2 years
1 year/2 years
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
CHD Vendée La Roche sur Yon
La Roche-sur-Yon, France
CHU de Nantes
Nantes, 44000, France
Komivi AGBETSIVI, DR
CHD Vendée La Roche sur Yon
VIGNARD Patricia, Dr
CH du Mans
Catherine Cattenoz, Dr
Rennes University Hospital
Jean -Richard EVEILLARD, Dr
CHU de Brest
48 participants (actual enrollment reported by the registry).
First Submitted
February 11, 2014
First Posted
February 14, 2014
Study Start
May 19, 2014
Actual (reported)Contact the study team to confirm eligibility.
François Puisieux, Pr
CHU de Lille
Jean -Yves NIEMIER, Dr
Central Hospital, Nancy, France
Frédérique Retornaz, Dr
CGD de Marseille
Véronique Brunel, Dr
Hôpital Européen de Marseille
Laure De Decker, Dr
Nantes University Hospital
Primary Completion
November 28, 2018
Actual (reported)Study Completion
November 28, 2018
Actual (reported)Last Updated
May 23, 2023
Record last verified: 2023-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: